Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis.
Neurology. 2021 Nov 9;97(19):e1870-e1885. doi: 10.1212/WNL.0000000000012753. Epub 2021 Oct 5.
Neurology. 2021.
PMID: 34610987
Free PMC article.